Zawya (registration) | Novartis reaffirms its ongoing commitment to improving transplant patients' lives Zawya (registration) "It is very important to tell patients that their immunosuppressive regimen is not nephrotoxic, that is, it will have minimal side-effects, and that it will not be associated with chronic allograft nephropathy. Moreover, the immunosuppressive protocol ... |
